ArticleScience (New York, N.Y.)2011

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.

Fubin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.